Pulmonic SAPIEN XT THV

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

April 30, 2017

Conditions
Pulmonary Valve Malfunction
Interventions
OTHER

SAPIEN XT

Patients that have undergone percutaneous implantation of an Edwards SAPIEN XT Transcatheter Heart Valve in the pulmonic position at the time of data collection

Trial Locations (6)

8091

Universitätshospital Zürich, Zurich

Unknown

Gent University Hospital, Ghent

UZ Leuven, Leuven

V6Z 1Y6

St Pauls Hospital, Vancouver

M5G 2C4

Toronto General, Toronto

G1V 4G5

Hospital Laval, Ste Foy, Montreal

All Listed Sponsors
collaborator

Estimate, GmbH

INDUSTRY

lead

Institut für Pharmakologie und Präventive Medizin

NETWORK

NCT02302131 - Pulmonic SAPIEN XT THV | Biotech Hunter | Biotech Hunter